Destabilization of the SHP2 and SHP1 protein tyrosine phosphatase domains by a non-conserved "backdoor" cysteine

被引:0
|
作者
Yarnall, Matthew T. N. [1 ]
Kim, Sean H. [1 ]
Korntner, Samuel [1 ]
Bishop, Anthony C. [1 ]
机构
[1] Amherst Coll, Dept Chem, Amherst, MA 01002 USA
基金
美国国家卫生研究院;
关键词
Protein tyrosine phosphatases; Backdoor cysteines; SHP1; SHP2; PTP1B; Protein stability; REDOX REGULATION; ALLOSTERIC SITE; MUTATIONS; INHIBITION; PTPN11;
D O I
10.1016/j.bbrep.2022.101370
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein tyrosine phosphatases (PTPs) are critical regulators of cellular signal transduction that catalyze the hydrolytic dephosphorylation of phosphotyrosine in substrate proteins. Among several conserved features in classical PTP domains are an active-site cysteine residue that is necessary for catalysis and a "backdoor" cysteine residue that can serve to protect the active-site cysteine from irreversible oxidation. Curiously, two biologically important phosphatases, Src homology domain-containing PTPs 2 and 1 (SHP2 and SHP1), each contain an additional backdoor cysteine residue at a position of the PTP domain that is occupied by proline in almost all other classical PTPs (position 333 in human SHP2 numbering). Here we show that the presence of cysteine 333 significantly destabilizes the fold of the PTP domains in the SHPs. We find that replacement of cysteine 333 with proline confers increased thermal stability on the SHP2 and SHP1 PTP domains, as measured by temperature -dependent activity assays and differential scanning fluorimetry. Conversely, we show that substantial destabi-lization of the PTP-domain fold is conferred by introduction of a non-natural cysteine residue in a non-SHP PTP that contains proline at the 333 position. It has previously been suggested that the extra backdoor cysteine of the SHP PTPs may work in tandem with the conserved backdoor cysteine to provide protection from irreversible oxidative enzyme inactivation. If so, our current results suggest that, during the course of mammalian evolution, the SHP proteins have developed extra protection from oxidation at the cost of the thermal instability that is conferred by the presence of their PTP domains' second backdoor cysteine.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Identification of an allosteric benzothiazolopyrimidone inhibitor of the oncogenic protein tyrosine phosphatase SHP2
    LaRochelle, Jonathan R.
    Fodor, Michelle
    Ellegast, Jana M.
    Liu, Xiaoxi
    Vemulapalli, Vidyasiri
    Mohseni, Morvarid
    Stams, Travis
    Buhrlage, Sara J.
    Stegmaier, Kimberly
    LaMarche, Matthew J.
    Acker, Michael G.
    Blacklow, Stephen C.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (24) : 6479 - 6485
  • [32] Regulation of ACh receptor clustering by the tyrosine phosphatase Shp2
    Zhao, Xiaotao T.
    Qian, Yueping K.
    Chan, Ariel W. S.
    Madhavan, Raghavan
    Peng, H. Benjamin
    DEVELOPMENTAL NEUROBIOLOGY, 2007, 67 (13) : 1789 - 1801
  • [33] The tyrosine phosphatase Shp2 (PTPN11) in cancer
    Gordon Chan
    Demetrios Kalaitzidis
    Benjamin G. Neel
    Cancer and Metastasis Reviews, 2008, 27 : 179 - 192
  • [34] The tyrosine phosphatase Shp2 (PTPN11) in cancer
    Chan, Gordon
    Kalaitzidis, Demetrios
    Neel, Benjamin G.
    CANCER AND METASTASIS REVIEWS, 2008, 27 (02) : 179 - 192
  • [35] The Toxoplasma secreted effector TgWIP modulates dendritic cell motility by activating host tyrosine phosphatases Shp1 and Shp2
    Morales, Pavel
    Brown, Abbigale J.
    Sangare, Lamba Omar
    Yang, Sheng
    Kuihon, Simon V. N. P.
    Chen, Baoyu
    Saeij, Jeroen P. J.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2024, 81 (01)
  • [36] The Tyrosine Phosphatase SHP2: A New Target for Insulin Resistance?
    Saint-Laurent, Celine
    Mazeyrie, Laurene
    Tajan, Mylene
    Paccoud, Romain
    Castan-Laurell, Isabelle
    Valet, Philippe
    Edouard, Thomas
    Pradere, Jean-Philippe
    Dray, Cedric
    Yart, Armelle
    BIOMEDICINES, 2022, 10 (09)
  • [37] Molecular features underlying differential SHP1/SHP2 binding of immune checkpoint receptors
    Xu, Xiaozheng
    Masubuchi, Takeya
    Cai, Qixu
    Zhao, Yunlong
    Hui, Enfu
    ELIFE, 2021, 10
  • [38] Megakaryocyte-specific deletion of the protein-tyrosine phosphatases Shp1 and Shp2 causes abnormal megakaryocyte development, platelet production, and function
    Mazharian, Alexandra
    Mori, Jun
    Wang, Ying-Jie
    Heising, Silke
    Neel, Benjamin G.
    Watson, Steve P.
    Senis, Yotis A.
    BLOOD, 2013, 121 (20) : 4205 - 4220
  • [39] Protein tyrosine phosphatase SHP2 is tyrosine phosphorylated in boar sperm and plays a role in capacitation
    Gonzalez-Fernandez, L.
    Ortega-Ferrusola, C.
    Macias-Garcia, B.
    Salido, G. M.
    Pena, F. J.
    Tapia, J. A.
    REPRODUCTION IN DOMESTIC ANIMALS, 2008, 43 : 76 - 76
  • [40] β-chemokine receptor CCR5 signals through SHP1, SHP2, and Syk
    Ganju, RK
    Brubaker, SA
    Chernock, RD
    Avraham, S
    Groopman, JE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (23) : 17263 - 17268